STUDY OF DRUG UTILIZATION PATTERN OF CALCIUM, VITAMIN D SUPPLEMENTS, AND ANTI-OSTEOPOROSIS DRUGS IN PATIENTS WITH OSTEOPOROTIC FRACTURE: A PROSPECTIVE CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.22159/ajpcr.2018.v11i12.27666Keywords:
Osteoporotic fractures, Calcium, Vitamin D supplements, Prescribing patternAbstract
Objective: This study was carried out to assess the drug utilization pattern of calcium, Vitamin D supplements, and anti-osteoporosis drugs in patients with osteoporotic fracture in an Indian teaching hospital.
Methods: A cross-sectional study was carried out for 6 months in outpatients receiving treatment from the orthopedic department of an Indian teaching hospital. Demographic details, comorbidities, types of fracture, laboratory parameters, and drug therapy were collected from the patient case records who met the study criteria and documented in the data collection form. All the collected details were later analyzed using descriptive statistics.
Results: A total of 73 patient's prescriptions were reviewed, in which 45.2% were male and 54.8% were female. Majority of the patients were in the age group of 50–60 years with mean age of 63.52±11.06 years. Hypertension (27.16%) was the highest comorbidity identified in the study followed by diabetes (18.51%) and coronary artery disease (14.81%). Of the total patients, 65.75% were prescribed with calcium and Vitamin D supplements and 2.73% received bisphosphonates.
Conclusion: The study shows the pattern of drug use in elderly with osteoporotic fractures. Since calcium and Vitamin D are vital for treating osteoporotic fractures, adequate monitoring of serum levels of calcium and Vitamin D3 may help to prescribe doses with desired need and safety level.
Downloads
References
Jeon YK, Kim BH, Kim IJ. The diagnosis of osteoporosis. J Korean Med Assoc 2016;59:842-6.
Tavakoli-Ardakani M, Eshraghi A, Hajhossein Talasaz A, Salamzadeh J. A drug utilization evaluation study of amphotericin B in neutropenic patients in a teaching hospital in Iran. Iran J Pharm Res 2012;11:151-6.
Shah RB, Gajjar BM, Desai SV. A study on drug utilization pattern among geriatric patients assessed with anatomical therapeutic chemical classification/defined daily dose system in rural tertiary care teaching hospital. Int J Nutr Pharm Neurol Dis 2012;2:258-65.
Jackson RD, LaCroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, et al. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83.
Chapuy MC, Pamphile R, Paris E, Kempf C, Schlichting M, Arnaud S, et al. Combined calcium and vitamin D3 supplementation in elderly women: Confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: The decalyos II study. Osteoporos Int 2002;13:257-64.
Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, et al. Clinician’s guide to prevention and treatment of osteoporosis. Osteoporos Int 2014;25:2359-81.
Weycker D, Li X, Barron R, Bornheimer R, Chandler D. Hospitalizations for osteoporosis-related fractures: Economic costs and clinical outcomes. Bone Rep 2016;5:186-91.
Zam W. Vitamin D deficiency and depressive disorders: Review study of probable relationship. Int J Pharm Pharm Sci 2016;8:16-22.
Warensjö E, Byberg L, Melhus H, Gedeborg R, Mallmin H, Wolk A, et al. Dietary calcium intake and risk of fracture and osteoporosis: Prospective longitudinal cohort study. BMJ 2011;342:d1473.
Tripathy A, Adiga S, Shah HH, Shanbhag TV, Kumar MD. A retrospective study of clinical profile and drug prescribing pattern in osteoporosis in a tertiary care teaching hospital. Int J Pharm Pharm Sci 2015;7:390-3.
Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis. Lancet 2007;370:657-66.
O’Connell MB, Borchert SS. Osteoporosis and other metabolic bone diseases. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, editors. Pharmacotherapy: A Pathophysiological Approach. 9th ed. USA: Mc Graw-Hill Education; 2014. p. 1482-3.
Cho K, Cederholm T, Lökk J. Calcium intake in elderly patients with hip fractures. Food Nutr Res 2008;52:1-5.
Yoon DS, Lee YK, Ha YC, Kim HY. Inadequate dietary calcium and Vitamin D intake in patients with osteoporotic fracture. J Bone Metab 2016;23:55-61.
Sugimoto T, Sato M, Dehle FC, Brnabic AJ, Weston A, Burge R, et al. Lifestyle-related metabolic disorders, osteoporosis, and fracture risk in Asia: A Systematic review. Value Health Reg Issues 2016;9:49-56.
McFarlane SI, Muniyappa R, Shin JJ, Bahtiyar G, Sowers JR. Osteoporosis and cardiovascular disease: Brittle bones and boned arteries, is there a link? Endocrine 2004;23:1-0.
Food Sources of Calcium and Vitamin D; 2017. Available from: http:// www.healthlinkbc.Ca/sources-calcium-vitamin-D.
Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing 2010;39:203-9.
Kim SH, Ko YB, Lee YK, Hong SW, Choi HJ, Ha YC, et al. National utilization of calcium supplements in patients with osteoporotic hip fracture in Korea. J Bone Metab 2013;20:99-103.
Castro-Lionard K, Dargent-Molina P, Fermanian C, Gonthier R, Cassou B. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: Patterns of use and associated factors. Drugs Aging 2013;30:1029-38.
Patel NS, Shah RB, Buch JG. Study on drug utilization pattern of non-steroidal anti-inflammatory drugs assessed with anatomical therapeutic chemical classification/defined daily dose system in an orthopedics department. Drug Ther Perspect 2015;31:358-64.
Shehnaz SI, Arifulla M, Sreedharan J, Sam KG. Prescribing patterns in orthopedics outpatient department in GMC Hospital, Ajman, UAE. Gulf Med J ASM 2014;3:S120-31.
Kanagasanthosh K, Topno I. A study on recent trends of prescribing pattern in orthopedics out-patient department from a tertiary care teaching hospital. Int J Pharm Technol 2015;6:7549-59.
Published
How to Cite
Issue
Section
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
